Search Within

Pallawi Torka

Formats
  1. Meeting Abstract (43)
  2. Journal Article (14)
  3. Research Letter (3)
  4. Correspondence (2)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Center for Hematologic Malignancies (31)
  2. Department of Medicine (31)
  3. Hematologic Malignancies, Division of (31)
  4. Lymphoma (31)
  5. Hematology-Oncology Fellows (29)
  6. Sloan Kettering Institute Postdocs (28)

More Groups

People
  1. Paul Hamlin (30)
  2. Anita Kumar (28)
  3. Paola Ghione (28)
  4. Andrew Zelenetz (27)
  5. Gilles Salles (27)
  6. Lorenzo Falchi (27)

More People

Years
  1. 2025 (10)
  2. 2024 (27)
  3. 2023 (27)
Publications
  1. Blood (39)
  2. Blood Cancer Journal (4)
  3. Hematological Oncology (4)
  4. Blood Advances (3)
  5. Clinical Lymphoma, Myeloma and Leukemia (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (42)
  2. Elsevier Inc. (4)
  3. Nature Publishing Group (4)
  4. Wiley Blackwell (4)
  5. Biomed Central Ltd (3)
  6. American Society of Clinical Oncology (2)

More Publishers

Results (64)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: Insights from a retrospective analysis
    Journal Article

    Luttwak, E.; Robin, E. T.; Drill, E.; Boardman, A.; Caron, P.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Nivolumab-AVD versus brentuximab vedotin-AVD in older patients with advanced-stage classic Hodgkin Lymphoma enrolled on S1826
    Journal Article

    Rutherford, S. C.; Li, H.; Herrera, A. F.; Leblanc, M.; Ahmed, S.; Davison, K.; Parsons, S. K.; Unger, J. M.; Perry, A. M.; Casulo, C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • SOHO state of the art updates and next questions: Diffuse large B-cell lymphoma in older adults: A comprehensive review
    Review

    Iyengar, V.; Hamlin, P.; Torka, P.
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • Representation of older adults in registrational trials associated with therapeutic approvals in diffuse large B-cell lymphoma
    Journal Article

    Juthani, R.; Pugh, K.; Neuendorff, N. R.; Torka, P.
    Journal of Geriatric Oncology (2025)

    Fulltext@MSK | Save
  • Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - A US multisite study
    Correspondence

    Epperla, N.; Shouse, G.; Grover, N. S.; Torka, P.; Annunzio, K.; Watkins, M.; Anampa-Guzmán, A.; Christian, B.; Thomas, C.; Barta, S. K.; more...
    Experimental Hematology and Oncology (2025)

    Fulltext@MSK | Save
  • Impact of age on biology, presentation and outcomes in marginal zone lymphoma: Results from a multicenter cohort study
    Journal Article

    Torka, P.; Grover, N. S.; Voorhees, T. J.; Karmali, R.; Annunzio, K.; Watkins, M. P.; Anampa-Guzmán, A.; Reves, H.; Tavakkoli, M.; Christian, B.; more...
    Hematological Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: A real world analysis from 15 U.S. academic centers
    Journal Article

    Voorhees, T. J.; McLaughlin, E. M.; Torka, P.; Florindez, J.; Kim, N. H.; Moyo, T. K.; Reves, H.; Sumransub, N.; Deshpande, S.; Rose, A.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Double hit & double expressor lymphomas: A multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy
    Journal Article

    Karmali, R.; Shouse, G.; Torka, P.; Moyo, T. K.; Romancik, J.; Barta, S. K.; Bhansali, R.; Cohen, J. B.; Shah, N. N.; Zurko, J.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: Real-life experience
    Journal Article

    Cassanello, G.; Drill, E.; Rivas-Delgado, A.; Okwali, M.; Isgor, I.; Caron, P. C.; Epstein-Peterson, Z.; Ghione, P.; Hamlin, P. A.; Lue, J. K.; more...
    Haematologica (2025)

    Fulltext@MSK | Save